Annabel Werumeus Buning
Papers
1
Total Citations
25
H-Index
1
About
Annabel Werumeus Buning is a leading researcher in pharmaceutical technology and patient safety, with a primary focus on the safe handling of hazardous drugs. Her work is pivotal in advancing the sterile compounding of cytotoxic medications, directly addressing critical risks of occupational exposure in hospital pharmacies. Her most cited study, a 2019 comparative analysis, rigorously assessed environmental and external cross-contamination during the preparation of 5-fluorouracil and cyclophosphamide. By contrasting a robotic system (APOTECAchemo) with conventional manual compounding, she provided groundbreaking evidence on contamination control. This work, with 25 citations, has become a cornerstone for institutions evaluating automation to enhance worker safety and drug purity. Werumeus Buning’s contributions are instrumental in shaping best practices for aseptic preparation, reducing contamination risks, and promoting the adoption of robotic technologies in clinical settings. Her research not only advances pharmaceutical engineering but also underscores a deep commitment to protecting healthcare professionals and patients from the dangers of cytotoxic exposure.
Research Focus
Key Achievements
Top Papers
- 1